111 related articles for article (PubMed ID: 8104685)
1. Soluble intercellular adhesion molecule 1 (sICAM-1) and malignant melanoma.
Viac J; Gueniche A; Faure M; Claudy A
Cancer Lett; 1993 Aug; 72(3):191-4. PubMed ID: 8104685
[TBL] [Abstract][Full Text] [Related]
2. Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage.
Schadendorf D; Diehl S; Zuberbier T; Schadendorf C; Henz BM
Dermatology; 1996; 192(2):89-93. PubMed ID: 8829517
[TBL] [Abstract][Full Text] [Related]
3. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
4. Soluble intercellular adhesion molecule-1 levels in patients with psoriasis.
Schopf RE; Naumann S; Rehder M; Morsches B
Br J Dermatol; 1993 Jan; 128(1):34-7. PubMed ID: 8094011
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of sICAM-1 and 5-S-cysteinyldopa as markers of melanoma progression.
Hirai S; Kageshita T; Kimura T; Tsujisaki M; Imai K; Wakamatsu K; Ito S; Ono T
Melanoma Res; 1997 Feb; 7(1):58-62. PubMed ID: 9067966
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of serum levels of soluble intercellular adhesion molecule-1 and soluble L-selectin in malignant melanoma.
Yamada M; Yanaba K; Takehara K; Sato S
Arch Dermatol Res; 2005 Dec; 297(6):256-60. PubMed ID: 16222535
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous measurement of circulating intercellular adhesion molecule-1 and serum copper zinc superoxide dismutase activity in patients with malignant melanoma.
Wollina U; Karte K; Olbertz K; Hipler UC
Oncol Rep; 1998; 5(2):473-6. PubMed ID: 9468582
[TBL] [Abstract][Full Text] [Related]
8. Differential levels of soluble intercellular adhesion molecule-1 (sICAM-1) in early breast cancer and benign breast lesions.
Altomonte M; Fonsatti E; Lamaj E; Cattarossi I; Cattelan A; Maio M
Breast Cancer Res Treat; 1999 Nov; 58(1):19-23. PubMed ID: 10634514
[TBL] [Abstract][Full Text] [Related]
9. Soluble intercellular adhesion molecule-1 in patients with lung cancer and benign lung diseases.
Sprenger A; Schardt C; Rotsch M; Zehrer M; Wolf M; Havemann K; Heymanns J
J Cancer Res Clin Oncol; 1997; 123(11-12):632-8. PubMed ID: 9620222
[TBL] [Abstract][Full Text] [Related]
10. The serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble gp130 (sgp130) in different tumour stages. Correlation between the two parameters in progression of malignancy.
Kovacs E
Biomed Pharmacother; 2005 Oct; 59(9):498-500. PubMed ID: 16202558
[TBL] [Abstract][Full Text] [Related]
11. Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma.
Franzke A; Probst-Kepper M; Buer J; Duensing S; Hoffmann R; Wittke F; Volkenandt M; Ganser A; Atzpodien J
Br J Cancer; 1998 Jul; 78(1):40-5. PubMed ID: 9662248
[TBL] [Abstract][Full Text] [Related]
12. Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma.
De Bellis A; Bizzarro A; Gattoni A; Romano C; Di Martino S; Sinisi AA; Abbadessa S; Bellastella A
J Clin Endocrinol Metab; 1995 Jul; 80(7):2118-21. PubMed ID: 7541801
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of soluble adhesion molecules ICAM-1 and ELAM-1 in patients with severe atopic eczema and influence of UVA1 treatment.
Kowalzick L; Kleinheinz A; Neuber K; Weichenthal M; Köhler I; Ring J
Dermatology; 1995; 190(1):14-8. PubMed ID: 7534511
[TBL] [Abstract][Full Text] [Related]
14. Soluble intercellular adhesion molecule-1 and serum cytokines in melanoma patients treated with liposomes containing muramyl tripeptide.
Favaro D; Santarosa M; Quaia M; Spada A; Freschi A; Talamini R; Galligioni E
Tumori; 1995; 81(3):185-90. PubMed ID: 7571025
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor (TNF) soluble receptors in malignant melanoma: correlation with soluble ICAM-1 levels.
Viac J; Vincent C; Palacio S; Schmitt D; Claudy A
Eur J Cancer; 1996 Mar; 32A(3):447-9. PubMed ID: 8814690
[TBL] [Abstract][Full Text] [Related]
17. Investigation of oestrogen receptors, sex steroids and soluble adhesion molecules in the progression of malignant melanoma.
Miller JG; Gee J; Price A; Garbe C; Wagner M; Mac Neil S
Melanoma Res; 1997 Jun; 7(3):197-208. PubMed ID: 9195558
[TBL] [Abstract][Full Text] [Related]
18. Detection of soluble adhesion molecules in pleural effusions.
Hoffmann JC; Krüger H; Lührs J; Hamm H
Chest; 1996 Jul; 110(1):107-13. PubMed ID: 8681612
[TBL] [Abstract][Full Text] [Related]
19. Plasma markers for identifying patients with metastatic melanoma.
Kluger HM; Hoyt K; Bacchiocchi A; Mayer T; Kirsch J; Kluger Y; Sznol M; Ariyan S; Molinaro A; Halaban R
Clin Cancer Res; 2011 Apr; 17(8):2417-25. PubMed ID: 21487066
[TBL] [Abstract][Full Text] [Related]
20. [Soluble forms of adhesion molecules sELAM-1 and sICAM-1 in Graves disease and toxic nodular goiter].
Modelska-Ziółkiewicz A; Gembicki M; Sowiński J
Pol Arch Med Wewn; 2003 May; 109(5):463-8. PubMed ID: 14768174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
